K. Nakazawa

3.1k citations
85 papers · 1.3k indexed · h-index 17
Topics
Renal Diseases and Glomerulopathies (15 papers)Chronic Kidney Disease and Diabetes (14 papers)Liver physiology and pathology (5 papers)

In The Last Decade

K. Nakazawa

81 papers receiving 1.3k citations

Peers

K. Nakazawa
Comparison fields: 5 of 108
  • Surgery 482
  • Rheumatology 480
  • Epidemiology 299
  • Molecular Biology 219
  • Nephrology 130
Replace Eiichi Konishi with:
Eiichi Konishi Japan
Hiroto Tsuboi Japan
Karen E. Heath Spain
Luigi Bisceglia Italy
Carlos Alberto von Mühlen Brazil
Koji Okudela Japan
Susumu Ishikawa Japan
Kristin Moreth Germany
Bernard Gasser France
David Gibson Ireland
K. Nakazawa relative to Eiichi Konishi Japan Eiichi Konishi's profile →
Citations per field
00.5×3.6×
Eiichi Konishi · 1×
Citations per year

Countries citing papers authored by K. Nakazawa

Since Specialization
Citations

This map shows the geographic impact of K. Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Nakazawa more than expected).

Fields of papers citing papers by K. Nakazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Nakazawa. The network helps show where K. Nakazawa may publish in the future.

Co-authorship network of co-authors of K. Nakazawa

This figure shows the co-authorship network connecting the top 25 collaborators of K. Nakazawa. A scholar is included among the top collaborators of K. Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Nakazawa. K. Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 5
4 6
5 4
6 0
7 3
8 3
9 13
10 16
11 1
12 14
13
DEVELOPMENT OF DRUG METABOLISM SIMULATOR USING PUF/HEPATOCYTE SPHEROID CULTURE. -STUDY OF ACETAMINOPHEN METABOLISM BY HYBRID ARTIFICIAL LIVER SYSTEM-
1
14 2
15 8
16 62
17 10
18 7
19 2
20 10

About K. Nakazawa

K. Nakazawa is a scholar working on Nephrology, Sensory Systems and Hepatology, having authored 85 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (14 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Rheumatology (480 citations), Sensory Systems (103 citations) and Nephrology (130 citations). K. Nakazawa has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Shigeyuki Kawa, Hisashi Shimojo, Masahisa Wajiki, Kendo Kiyosawa, Yasuhide Ochi, Hiroshi Unno, Bradley A. Schulte, Hidekazu Shigematsu, S. S. Spicer and Nobuo Itoh. Their work appears in journals such as The Lancet, Circulation and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026